Related CELGIs It Closing Time At The Biotech Bar?Weekly Options Outlook: Bulls Leave Money On The Table Despite A Week-End WinCelgene backs away from development of mAb for blood cancer(Seeking Alpha)Related ILMNIs It Closing Time At The Biotech Bar?3 Niche ETFs Breaking Out3 Excellent Biotech Stocks to Buy on the Dip – Stocks in the News(Zacks)By and large, the short […]
View photo.By and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG), Illumina, Inc. (NASDAQ: ILMN) and Medivation Inc (NASDAQ: MDVN) saw double-digit percentage upswings in their short interest.Here we take a quick look at how these three stocks have fared […]
Source: Celgene Corp.The volatility that comes with investing in biotech stocks can test the patience of even the most risk-tolerant investor. Many investors may be better served focusing on companies with proven track records of success rather than concentrating on emerging biotech stocks that are more promise than profit. Fortunately, investing in proven performers doesn’t have to mean sacrificing growth! […]
Source: Celgene CorporationThe biotechnology industry has been one of the best performing baskets in the stock market this year, but just because biotech stocks were kind to investors this year doesn’t necessarily mean that they’ll rally next year, too.Biotech stocks can move significantly higher or lower in any given year due to investor’s reaction to data from ongoing drug trials, […]
